Brief: Spago Nanomedical Updates On Clinical Phase IIa Study Spagopix-02

Spago Nanomedical AB (publ)

28/06/2023 07:09

June 28 (Reuters) - Spago Nanomedical AB (publ)  SPAGO.ST :
    * UPDATES ON THE CLINICAL PHASE IIA STUDY SPAGOPIX-02
    * PRELIMINARY ANALYSIS OF DATA FROM PHASE IIA CLINICAL STUDY SPAGOPIX-02 SHOWS THAT SN132D
HAS A
GOOD SAFETY PROFILE IN PATIENTS WITH ENDOMETRIOSIS.

Source text for Eikon:  ID:nMFN9XJcbm 
Further company coverage:  SPAGO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))